Clinical Trials Directory

Trials / Completed

CompletedNCT00564811

Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom)

Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom) on the Nutritional State and Liver Biochemistry in Hepatitis C Patients.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
UPECLIN HC FM Botucatu Unesp · Academic / Other
Sex
All
Age
24 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of the study was to verify the influence of Agaricus blazei (Murrill) ss. Heinemann (A. blazei) on the evolution of nutritional state and liver function in hepatitis C patients.

Detailed description

Ten patients were studied (5 - GI - not taking A. blazei - and 5 - G2 - taking A. blazei), from both sexes, with positive Anti-VHC and a healthy nutritional state, admitted into in the viral hepatitis ward. Diagnosis and treatment for hepatitis C concurred with the regulations of the Ministry of Health and nutritional evaluation was performed in 3 moments according to anthropometrical, bioimpedance, biochemical and dietary standards, with duration of 6 months. The consumption of A. blazei (10g/day) in dehydrated powder was concomitant with antiviral therapy (conventional or pegylated interferon associated with ribavirin) with duration of 5 months.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAgaricus blazei (Murrill) ss. Heinemann (sun mushroom)Agaricus blazei powder, 10 grams/day, for 5 months

Timeline

Start date
2003-03-01
Completion
2004-09-01
First posted
2007-11-28
Last updated
2015-05-29

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00564811. Inclusion in this directory is not an endorsement.